[The platelet inhibitor problem]
- PMID: 7015489
[The platelet inhibitor problem]
Abstract
Some problems encountered in interpreting randomized clinical trials on the secondary prevention of myocardial infarction and transient cerebral ischemic attacks are discussed. With regard to acetylsalicylic acid, the dosage, and some general side effects such as those observed in transfusions, are considered.
Similar articles
-
[Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].G Ital Cardiol. 1982;12(8):598-603. G Ital Cardiol. 1982. PMID: 6762978 Clinical Trial. Italian. No abstract available.
-
Trials of antiplatelet drugs: some methodological considerations.Rev Epidemiol Sante Publique. 1979 Sep 18;27(2):87-90. Rev Epidemiol Sante Publique. 1979. PMID: 538303 No abstract available.
-
Clinical trials in thrombosis: secondary prevention of myocardial infarction.Thromb Haemost. 1976 Feb 29;35(1):49-56. Thromb Haemost. 1976. PMID: 785688 Review.
-
Platelet aggregation and atherosclerosis.Heart Lung. 1986 Mar;15(2):211-4. Heart Lung. 1986. PMID: 3633253
-
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].Ann Med Interne (Paris). 1983;134(2):79-83. Ann Med Interne (Paris). 1983. PMID: 6349464 Review. French. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical